Pharmaceutical manufacturing

In this image provided by Public Health Emergency, a department of Health and Human Services, Rick Bright is shown in his official photo from April 27, 2017, in Washington. Bright filed a complaint May 5, 2020, with the Office of Special Counsel, a government agency responsible for whistleblower complaints. He’s the former director of the Biomedical Advanced Research and Development Authority. Bright alleges he was removed from his job and reassigned to a lesser role because he resisted political pressure to allow widespread use of hydroxychloroquine, a malaria drug favored by President Donald Trump. (Health and Human Services via AP)
Associated Press
May 05, 2020 - 6:04 pm
WASHINGTON (AP) — The Trump administration failed to prepare for the onslaught of the coronavirus, then sought a quick fix by trying to rush an unproven drug to patients, a senior government scientist alleged in a whistleblower complaint Tuesday. Dr. Rick Bright, former director of the Biomedical...
Read More
In this March 2020 photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP)
Associated Press
April 06, 2020 - 5:35 pm
The new coronavirus made Dr. Jag Singh a patient at his own hospital. His alarm grew as he saw an X-ray of his pneumonia-choked lungs and colleagues asked his wishes about life support while wheeling him into Massachusetts General’s intensive care unit. When they offered him a chance to help test...
Read More
FILE - In this July 9, 2015, file photo, a man walks outside the headquarters of Gilead Sciences in Foster City, Calif. Gilead Sciences said Wednesday, March 25, 2020 it will give up the specialty status it received days earlier for its COVID-19 drug amid public outrage that the company was seeking to boost the profits of its treatment. (AP Photo/Eric Risberg, File)
Associated Press
March 25, 2020 - 2:55 pm
WASHINGTON (AP) — Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and boost profits for its treatment. Gilead Sciences said it will ask U.S. regulators to revoke the so-...
Read More
People walk past a convenient store where the latest cover of a magazine is stuck on a pillar outside of it on Sunday, March 15, 2020, in New York. President Donald Trump on Sunday called on Americans to cease hoarding groceries and other supplies, while one of the nation's most senior public health officials called on the nation to act with more urgency to safeguard their health as the coronavirus outbreak continued to spread across the United States. (AP Photo/Wong Maye-E)
Associated Press
March 16, 2020 - 5:52 pm
Millions of people are stocking up and holing up at home a as a growing number of governments fight to bring the coronavirus under control. The number of reported cases worldwide topped 175,000 with 6,700 deaths. More than 77,000 people have recovered from the illness. These are some of the latest...
Read More
Dr. Lisa Jackson, a senior investigator at the Kaiser Permanente Washington Health Research Institute, works in her office with an image of COVID-19 taped to her door, Sunday, March 15, 2020, in Seattle. Jackson is leading the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, which was given to the first volunteer in the study by injection, Monday, March 16. (AP Photo/Ted S. Warren)
Associated Press
March 16, 2020 - 11:37 am
SEATTLE (AP) — U.S. researchers gave the first shot to the first person in a test of an experimental coronavirus vaccine Monday -- leading off a worldwide hunt for protection even as the pandemic surges. With a careful jab in a healthy volunteer’s arm, scientists at the Kaiser Permanente Washington...
Read More
President Donald Trump with Vice President Mike Pence, speaks during a coronavirus briefing with Airline CEOs in the Roosevelt Room of the White House, Wednesday, March 4, 2020, in Washington. (AP Photo/Manuel Balce Ceneta)
Associated Press
March 06, 2020 - 7:56 am
WASHINGTON (AP) — President Donald Trump on Friday signed an $8.3 billion measure to help tackle the coronavirus outbreak that has killed 12 people in the U.S. and infected more than 200. The legislation provides federal public health agencies with money for vaccines, tests and potential treatments...
Read More
Vice President Mike Pence, center, joined at left by Dr. Deborah Birx, the coronavirus response coordinator, arrives at the Capitol to brief House members on the COVID-19 outbreak, in Washington, Wednesday, March 4, 2020. Congressional negotiators have reached agreement on an $8.3 billion bill to fund the government's response to the public health emergency. (AP Photo/J. Scott Applewhite)
Associated Press
March 05, 2020 - 11:08 pm
WASHINGTON (AP) — President Donald Trump is expected to sign an $8.3 billion measure to help tackle the coronavirus outbreak. The legislation would provide federal public health agencies money for vaccines, tests and potential treatments, and help state and local governments prepare for and respond...
Read More
A person wearing a mask walks past a sign banning visitors at the Life Care Center in Kirkland, Wash., near Seattle, Monday, March 2, 2020. Dozens of people associated with the facility are reportedly ill with respiratory symptoms or hospitalized and are being tested for the COVID-19 virus. (AP Photo/Ted S. Warren)
Associated Press
March 02, 2020 - 7:30 pm
SEATTLE (AP) — An increase in testing for the coronavirus began shedding light Monday on how the illness has spread in the United States, including in Washington state, where four people died at a nursing home and some schools were closed for disinfection. New diagnoses in several states pushed the...
Read More
President Donald Trump with Department of Health and Human Services Secretary Alex Azar, right, and other members of the president's coronavirus task force speaks during a news conference at the Brady press briefing room of the White House, Wednesday, Feb. 26, 2020, in Washington. (AP Photo/Manuel Balce Ceneta)
Associated Press
February 26, 2020 - 9:07 pm
WASHINGTON (AP) — President Donald Trump declared Wednesday that a widespread U.S. outbreak of the new respiratory virus sweeping the globe isn't inevitable even as top health authorities at his side warned Americans that more infections are coming. Shortly after Trump spoke, the government...
Read More
French lab scientists in hazmat gear inserting liquid in test tube manipulate potentially infected patient samples at Pasteur Institute in Paris, Thursday, Feb. 6, 2020. Scientists at the Pasteur Institute developed and shared a quick test for the new virus that is spreading worldwide, and are using genetic information about the coronavirus to develop a potential vaccine and treatments. (AP Photo/Francois Mori)
Associated Press
February 06, 2020 - 7:41 pm
WASHINGTON (AP) — The flu-like virus that exploded from China has researchers worldwide once again scrambling to find a vaccine against a surprise health threat, with no guarantee one will arrive in time. Just days after Chinese scientists shared the genetic map of the culprit coronavirus,...
Read More

Pages